Institut für Ernährungswissenschaft
Refine
Has Fulltext
- no (2)
Year of publication
- 2017 (2) (remove)
Document Type
- Other (2) (remove)
Language
- English (2)
Is part of the Bibliography
- yes (2)
Keywords
- DPP-4 inhibitors (1)
- Dipeptidyl peptidase IV (1)
- acute kidney injury (1)
- gliptins (1)
- ischemia reperfusion injury (1)
Institute
New data from the LEADER trial show that the glucagon-like peptide 1 receptor agonist liraglutide protects against diabetic nephropathy in patients with type 2 diabetes mellitus. The renoprotective efficacy of liraglutide is not, however, as great as that reported for the sodium-glucose cotransporter 2 inhibitor emplagiflozin in the EMPA-REG OUTCOME trial.
DPP4 inhibition prevents AKI
(2017)